Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD

OBJECTIVES: This study aimed to compare the effects of angiotensin-converting-enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) on the risk of pneumonia and severe exacerbations in patients with COPD. PATIENTS AND METHODS: All patients with COPD who used ACEis and ARBs for >90 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Wang, Ya-Hui, Wang, Cheng-Yi, Wang, Hao-Chien, Yu, Chong-Jen, Chen, Likwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846309/
https://www.ncbi.nlm.nih.gov/pubmed/29563786
http://dx.doi.org/10.2147/COPD.S158634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846309/
https://www.ncbi.nlm.nih.gov/pubmed/29563786
http://dx.doi.org/10.2147/COPD.S158634

Ejemplares similares